Alembic Pharmaceuticals Ltd announced that, Brexpiprazole tablets, which are used to treat schizophrenia and major depressive disorder, have received tentative approval from the United States Food and Drug Administration (FDA). Abbreviated New Drug Application (ANDA) Brexpiprazole Tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg have received […]
Continue Reading
Nelarabine Injection, an oncology drug developed by Shorla Oncology, has received US FDA approval for the treatment of T-cell Acute Lymphoblastic Leukemia (T-ALL) and T-cell Lymphoblastic Lymphoma (T-LBL). Nelarabine Injection offers patients a substitute for a product that has historically been scarce. Sharon Cunningham, CEO and co-founder of Shorla Oncology, said that they are very […]
Continue Reading
The US FDA approved Alaembic Pharma’s Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) in India. Patients with colon and rectal adenocarcinomas, breast adenocarcinomas, gastric adenocarcinomas, and pancreatic adenocarcinomas are treated with the injection. Fluorouracil Infusion has an expected market size of $5 million for a considerable length of time finishing December 2022, as indicated […]
Continue Reading
Zydus Lifesciences’ Acyclovir Cream, 5%, which is used to treat cold sores on the face and lips, received final approval from the United States Food and Drug Administration (FDA). Blisters known as cold sores are brought on by the herpes simplex virus. Acyclovir is a member of the antiviral class of drugs. The product will […]
Continue Reading
Granules India announced that its Abbreviated New Drug Application (ANDA) for Losartan Potassium Tablets USP, 25 mg, 50 mg, and 100 mg, received approval from the US Food and Drug Administration (FDA). Losartan Potassium is a bioequivalent to the reference recorded drug item (RLD), Cozaar Tablets of Organon LLC. The US Food and Drug Administration […]
Continue Reading
Brinton Pharmaceuticals Ltd. opened its Global Research and Development Centre in the UK, in an effort to expand internationally. UK MP, Nigel Huddleston said, he is delighted to be inaugurating this new facility in Runcorn, which will help their domestic healthcare sector and create highly-skilled jobs, as he unveiled the Global R&D Centre in Runcorn, […]
Continue Reading
On, February, 22, 2023, Moderna Inc. said that US regulators have given its experimental personalised mRNA skin cancer vaccine and Merck & Co.’s drug Keytruda the designation of breakthrough therapies as an additional treatment for high-risk patients. After the market closed Moderna shares rose 2.5% to $164. Based on data from a mid-stage drug study […]
Continue Reading
Pfizer Inc. announced that the US Food and Drug Organization (FDA) has approved a Biologics License Application (BLA) for its respiratory syncytial infection (RSV) antibody candidate, PF-06928316 or RSVpreF, to treat Mama LRTI and serious Mama LRTI brought in newborn children from birth as long as a half year old enough by dynamic vaccination of […]
Continue Reading
One of Fierce Pharma’s best three most expected drug dispatches of 2023 were likewise one of the year’s generally questionable. However, Apellis Pharmaceuticals achieved a second commercial approval for its C3 inhibitor pegcetacoplan on Friday, defying the industry’s losing trend in geographic atrophy (GA). The first treatment for GA, an advanced stage of age-related macular […]
Continue Reading
According to Caplin Point Laboratories Ltd., its subsidiary, Caplin Steriles Ltd., has received final FDA approval for carboprost tromethamine injection, which is used to treat postpartum hemorrhage caused by uterine atony. Postpartum hemorrhage, which results in excessive bleeding after delivery, is primarily caused by uterine atony. Carboprost Tromethamine Injection USP, 250 mcg single-dose vials have […]
Continue Reading